Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-02-28 | Steven M. Fruchtman, M.D.(10) 69,500 * Includes 63,124 shares of common stock issuable upon the exercise of warrants and options that are currently exercisable or exercisable within sixty days of February 16, 2018. |
| 2018-05-17 | Steven M. Fruchtman, M.D. is listed as a director but no software-related skills or technical background are mentioned. |
| 2019-04-29 | Dr. Fruchtman received his medical degree from New York Medical College and his B.A. from Cornell University. |
| 2020-04-23 | Dr. Fruchtman received his medical degree from New York Medical College and his B.A. from Cornell University. |
| 2021-01-13 | Steven M. Fruchtman, M.D. President and Chief Executive Officer |
| 2021-05-28 | Dr. Fruchtman received his medical degree from New York Medical College and his B.A. from Cornell University. |
| 2022-05-25 | Dr. Fruchtman received his medical degree from New York Medical College and his B.A. from Cornell University. He is currently a board member of the Bone Marrow & Cancer Foundation. |
| 2023-06-07 | Dr. Fruchtman received his medical degree from New York Medical College and his B.A. from Cornell University. |
| 2025-02-06 | Steven M. Fruchtman, M.D., listed as a director and former executive officer with no software background. |
Data sourced from SEC filings. Last updated: 2026-02-03